Administration: Inject under the skin (subcutaneously) in the abdomen, thigh, or upper arm
Muheem, A., Shakeel, F., Jahangir, M
While these medications offer significant benefits, it's essential to be aware of their safety profile and potential side effects
Further research is needed to fully understand the long-term effects and safety profile of this medication but the results of this study provide a promising foundation for future investigations
Maximus is not responsible for, nor will they bear any liability for, the content provided herein or any actions or outcomes resulting from or related to its use.
One in five semaglutide users experiences vomiting versus roughly one in seven tirzepatide users